Salix Pharmaceuticals Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
1,000
- Latest Deal Type
-
M&A
- (Cancelled)
- Latest Deal Amount
-
$10B
Salix Pharmaceuticals General Information
Description
Manufacturer of pharmaceutical products intended for the prevention and treatment of gastrointestinal diseases and disorders. The company offers treatments for overt hepatic encephalopathy, irritable bowel syndrome with diarrhea, irritable bowel syndrome with constipation, chronic idiopathic constipation, opioid-induced constipation, bowel preparation and ulcerative colitis.
Contact Information
Website
www.salix.comCorporate Office
- 400 Somerset Corporate Boulevard
- Bridgewater, NJ 08807
- United States
Salix Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 01-Dec-2016 | $10B | 0000 | Cancelled | Profitable | |
| 7. Merger/Acquisition | 01-Apr-2015 | 0000 | 00.000 | 0000 | Completed | Profitable |
| 6. Merger/Acquisition | 11-Mar-2015 | 000.00 | 000.00 | Cancelled | Profitable | |
| 5. Debt - General | 12-Dec-2013 | 00.00 | 00.000 | Completed | Profitable | |
| 4. Secondary Transaction - Open Market | 10-Sep-2009 | 000.00 | Completed | Profitable | ||
| 3. Secondary Transaction - Open Market | 31-Dec-2003 | 000.00 | Completed | Profitable | ||
| 2. PIPE | 20-Nov-2000 | $14.1M | $14.1M | Completed | Profitable | |
| 1. IPO | 01-May-1996 | Completed | Profitable |
Salix Pharmaceuticals Comparisons
Industry
Financing
Details
000000
000000
Salix Pharmaceuticals Competitors (31)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Company | Corporation | Tokyo, Japan | 00000 | 0000 | 000000000 | 0000 |
| Abbott India | Corporation | Mumbai, India | 0000 | 00000000 | ||
| GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | 00 | 00000000 | ||
| Viatris | Corporation | Canonsburg, PA | 00000 | 00000000 | ||
| Novartis India | Corporate Backed or Acquired | Mumbai, India | 00 | 00.000 | 0&0 |
Salix Pharmaceuticals Patents
Salix Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3038312-A1 | Solid dispersion forms of rifaximin | Pending | 30-Sep-2016 | 0000000000 | |
| EP-4137132-A1 | Solid dispersion forms of rifaximin | Pending | 30-Sep-2016 | 0000000000 | 0 |
| US-11311521-B2 | Solid dispersion forms of rifaximin | Active | 30-Sep-2016 | 0000000000 | 00 |
| ES-2929768-T3 | Rifaximin solid dispersion forms | Active | 30-Sep-2016 | 0000000000 | |
| US-20210205279-A1 | Solid dispersion forms of rifaximin | Active | 30-Sep-2016 | A61K31/437 |
Salix Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Salix Pharmaceuticals Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Deerfield Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
| EW Healthcare Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Oxford Bioscience Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
Salix Pharmaceuticals Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Atlantic Healthcare | 21-Mar-2016 | 00000 0000 | 000.00 | Pharmaceuticals | |
| Santarus | 03-Jan-2014 | 0000000000 | 00.00 | Pharmaceuticals | 0000000 0 |
| Oceana Therapeutics | 20-Dec-2011 | 0000000000 | 00000 | Pharmaceuticals | |
| Inkine Pharmaceuticals | 23-Jun-2005 | Merger/Acquisition | 00000 | Pharmaceuticals | 0000000 0 |
Salix Pharmaceuticals FAQs
-
When was Salix Pharmaceuticals founded?
Salix Pharmaceuticals was founded in 1989.
-
Who is the founder of Salix Pharmaceuticals?
Randy Hamilton and Lorin Johnson Ph.D are the founders of Salix Pharmaceuticals.
-
Where is Salix Pharmaceuticals headquartered?
Salix Pharmaceuticals is headquartered in Bridgewater, NJ.
-
What is the size of Salix Pharmaceuticals?
Salix Pharmaceuticals has 1,000 total employees.
-
What industry is Salix Pharmaceuticals in?
Salix Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Salix Pharmaceuticals a private or public company?
Salix Pharmaceuticals is a Private company.
-
What is the current valuation of Salix Pharmaceuticals?
The current valuation of Salix Pharmaceuticals is 0000.
-
What is Salix Pharmaceuticals’s current revenue?
The current revenue for Salix Pharmaceuticals is 000000.
-
How much funding has Salix Pharmaceuticals raised over time?
Salix Pharmaceuticals has raised $2.11B.
-
Who are Salix Pharmaceuticals’s investors?
Deerfield Management, EW Healthcare Partners, and Oxford Bioscience Partners have invested in Salix Pharmaceuticals.
-
Who are Salix Pharmaceuticals’s competitors?
Takeda Pharmaceutical Company, Abbott India, GlaxoSmithKline Consumer Nigeria, Viatris, and Novartis India are some of the 31 competitors of Salix Pharmaceuticals.
-
When was Salix Pharmaceuticals acquired?
Salix Pharmaceuticals was acquired on 01-Dec-2016.
-
Who acquired Salix Pharmaceuticals?
Salix Pharmaceuticals was acquired by Bausch Health Companies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
